Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐<scp>d</scp>‐Phe¹]‐Octreotide

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1993 • 1,563 citations

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

1991 • 843 citations

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1993 • 665 citations

LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN

1989 • 607 citations

Radioimmunotherapy of B-Cell Lymphoma with [¹³¹I]Anti-B1 (Anti-CD20) Antibody

1993 • 557 citations

Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.

1992 • 411 citations

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

1991 • 327 citations

Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue

1993 • 132 citations

The development of new radiopharmaceuticals

1990 • 24 citations

Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.

1989 • 18 citations